FDA Looking at Potentially Increased Mortality Risk with Gout Drug

The FDA is investigating whether the gout drug febuxostat (Uloric) is associated with an increased risk for heart-related mortality. This follows a postmarketing trial...
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news